Healio Rheumatology Current Issue
The following articles appeared in the print edition of Healio Rheumatology.
Table of Contents
- Two steps forward, one step back: Hunting for a game-changer in scleroderma Rob Volansky
-
- ACR recommends fourth dose of COVID-19 mRNA vaccine for patients on immunosuppressants Jason Laday
- WHO strongly recommends baricitinib plus corticosteroids for severe, critical COVID-19 Jason Laday
- Is fatigue the new frontier in rheumatology? Leonard H. Calabrese, DO
- FDA approves Skyrizi for adults with active psoriatic arthritis Jason Laday
- Colchicine as COVID-19 treatment suffers difficult year, but some hope remains Rob Volansky
- Hooked on Rheum with Kenneth Saag, MD Kenneth Saag, MD
- Academic rheumatologists generate $12.14 in revenue for every $1 they receive Jason Laday
- Aquatic exercise superior to physical therapy in relieving chronic lower back pain Jason Laday
-
- Biosimilar, originator DMARDs exhibit no differences in treatment retention Jason Laday
- COVID-19 vaccine uptake higher among patients with IMIDs than general population Jason Laday
- Early C-reactive protein 'not a good biomarker' for canakinumab impact on gout flares Jason Laday
- Hip osteoarthritis burden increasing 'in almost all countries' Jason Laday
- Immune dysfunction linked to 'substantial risk' for breakthrough COVID-19 infection Jason Laday
- More than 60% of patients with RA, PsA report side effects in days after methotrexate dose Jason Laday
- 'No clinically relevant effect': Duloxetine fails to impact chronic osteoarthritis pain Jason Laday
- Norway 'excellent example' of how to increase access to biosimilars Jason Laday
-
- Patients with gout 20% more likely to undergo lower extremity amputation Jason Laday
- Radiographic scoring system 'feasible, reproducible' to assess spur, sclerosis in gout Jason Laday
- Risk for 'more severe, critical' COVID-19 higher in RA vs. PsA, ulcerative colitis Jason Laday
- A Code of Its Own: ICD-10 code update finally 'legitimizes' nonradiographic axSpA Rob Volansky